OPTIMIZED HIGH-DOSE TABLET OF MESALAZINE

The present invention relates to an oral enteric high-dose tablet comprising mesalazine as the active substance as well as its use.

Saved in:
Bibliographic Details
Main Authors Greinwald, Roland, Pröls, Markus, Wilhelm, Rudolph, Nacak, Tanju
Format Patent
LanguageCroatian
English
Published 06.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to an oral enteric high-dose tablet comprising mesalazine as the active substance as well as its use.
Bibliography:Application Number: HR2019P002184T